NM_020661.4(AICDA):c.203G>A (p.Trp68Ter) AND not provided

Germline classification:: Pathogenic (1 submission)
Last evaluated:: Jan 1, 2023
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV003389747.11

Allele description [Variation Report for NM_020661.4(AICDA):c.203G>A (p.Trp68Ter)]

NM_020661.4(AICDA):c.203G>A (p.Trp68Ter)

Gene:

AICDA:activation induced cytidine deaminase [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

12p13.31

Genomic location:

Preferred name:

NM_020661.4(AICDA):c.203G>A (p.Trp68Ter)

HGVS:

NC_000012.12:g.8605439C>T
NG_011588.1:g.12408G>A
NM_001330343.2:c.203G>A
NM_020661.4:c.203G>AMANE SELECT
NP_001317272.1:p.Trp68Ter
NP_065712.1:p.Trp68Ter
LRG_17t1:c.203G>A
LRG_17:g.12408G>A
LRG_17p1:p.Trp68Ter
NC_000012.11:g.8758035C>T

Protein change:

W68*; TRP68TER

Links:

OMIM: 605257.0002; dbSNP: rs104894325

NCBI 1000 Genomes Browser:

rs104894325

Molecular consequence:

NM_001330343.2:c.203G>A - nonsense - [Sequence Ontology: SO:0001587]
NM_020661.4:c.203G>A - nonsense - [Sequence Ontology: SO:0001587]

Observations:

Condition(s)

Synonyms:: none provided; RECLASSIFIED - ADRA2C POLYMORPHISM; RECLASSIFIED - ADRB1 POLYMORPHISM
Identifiers:: MedGen: C3661900

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV004134383	CeGaT Center for Human Genetics Tuebingen	criteria provided, single submitter (CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2)	Pathogenic (Jan 1, 2023)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV004134383

CeGaT Center for Human Genetics Tuebingen

criteria provided, single submitter

(CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2)

Pathogenic
(Jan 1, 2023)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	yes	1	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From CeGaT Center for Human Genetics Tuebingen, SCV004134383.11

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	1	not provided	not provided	clinical testing	not provided

Description

AICDA: PVS1, PM2

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	yes	not provided	not provided	not provided		1	not provided	not provided	not provided

Last Updated: Dec 22, 2024

ClinVar

Relating variation to medicine